The company’s main focus is on the development, production and sale of contrast media for X-ray, computed tomography and magnetic resonance procedures, with an emphasis on radiology, neurology and oncology. At the same time, Sanochemia’s active pharmaceutical ingredient (API) synthesis business, which focuses on the development and production of active pharmaceutical ingredients (APIs) in the course of contract manufacturing as a CMO, is also impressive. The scope of activities ranges from the establishment of new laboratory processes and upscaling to production on a ton scale.

GMP-compliant production of high-quality pharmaceuticals in solid, liquid, semi-solid and injectable dosage forms rounds off the offering for customers. On-site partnerships with local B2B partners ensure adequate market access in over 35 countries, with plans to further intensify international expansion. A solid basis for future developments is provided by many years of experience as a manufacturer of contrast media for diagnostic imaging and active ingredients.